1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U.

    Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.

    PARKINSONISM & RELATED DISORDERS . 68: 40-45. Nº de citas: 9

    [doi:10.1016/j.parkreldis.2019.09.032]

  • Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.

    Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

    Frontiers in immunology . 10: 2403-2403. Nº de citas: 13

    [doi:10.3389/fimmu.2019.02403]

  • Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.

    Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL . 25(11): 1535-1538. Nº de citas: 3

    [doi:10.1177/1352458518786055]

  • Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.

    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD - CD27 - Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.

    JOURNAL OF IMMUNOLOGY . 203(6): 1650-1664. Nº de citas: 16

    [doi:10.4049/jimmunol.1801236]

  • Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, de-León Ruiz J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.

    Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.

    EUROPEAN JOURNAL OF NEUROLOGY . 26(9): 1200-1204. Nº de citas: 11

    [doi:10.1111/ene.13965]

  • Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

    Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

    Frontiers in immunology . 10: 1374-1374. Nº de citas: 23

    [doi:10.3389/fimmu.2019.01374]

  • Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

    REVISTA DE NEUROLOGIA . 68(11): 468-479.

    [doi:10.33588/rn.6811.2019121]

  • van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

    gMS-Classifier1 does not predict disability progression in multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL . 25(7): 1010-1011.

    [doi:10.1177/1352458518798048]

  • Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

    Perception of stigma in patients with primary progressive multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 5(2): . Nº de citas: 5

    [doi:10.1177/2055217319852717]

  • Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Factors associated with dimethyl fumarate-induced lymphopenia.

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 398: 4-8. Nº de citas: 19

    [doi:10.1016/j.jns.2019.01.007]

  • Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

    Annals of Clinical and Translational Neurology . 6(2): 355-363. Nº de citas: 10

    [doi:10.1002/acn3.711]

  • Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.

    Biomarkers for Multiple Sclerosis

    RSC Drug Discovery Series . 70: 55-75.

    [doi:10.1039/9781788016070]

  • Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

    Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

    CLINICA CHIMICA ACTA . 488: 135-142. Nº de citas: 1

    [doi:10.1016/j.cca.2018.11.008]

  • Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

    Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

    JOURNAL OF NEUROINFLAMMATION . 15(1): 296-296. Nº de citas: 5

    [doi:10.1186/s12974-018-1336-9]

  • Perez Perez, S., Dominguez Mozo, M. I., Medina, S., Villarubia, N., Alonso Gomez, A., Garcia Martinez, M. A., Costa Frossard, L., Alvarez Cermeno, J. C., Arroyo Gonzalez, R., Villar Guimerans, L. M., Alvarez Lafuente, R..

    Short chain fatty acids levels in plasma of multiple sclerosis patients: a correlation with the disability of the disease and the activation of the immune system

    MULTIPLE SCLEROSIS JOURNAL . 24: 601-602. Nº de citas: 1

  • Alonso-Canovas A, Lopez-Sendon Moreno JL, Buisan J, Sainz de la Maza S, Costa-Frossard L, Garcia-Ribas G, de Felipe-Mimbrera A, Matute-Lozano MC, Zarza Sanz B, Toledano Delgado R, Corral I, Masjuan J, Martinez-Castrillo JC.

    Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.

    JOURNAL OF NEUROLOGY . 265(10): 2363-2369. Nº de citas: 3

    [doi:10.1007/s00415-018-9006-5]

  • Malhotra S, Sorosina M, Río J, Peroni S, Midaglia L, Villar LM, Álvarez-Cermeño JC, Schroeder I, Esposito F, Clarelli F, Zettl UK, Lechner-Scott J, Spataro N, Navarro A, Comi G, Montalban X, Martinelli-Boneschi F, Comabella M.

    NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

    MULTIPLE SCLEROSIS JOURNAL . 24(11): 1507-1510. Nº de citas: 6

    [doi:10.1177/1352458517739137]

  • Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M.

    Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

    JOURNAL OF NEUROINFLAMMATION . 15(1): 265-265. Nº de citas: 17

    [doi:10.1186/s12974-018-1307-1]